These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7808785)

  • 21. Comparison of simple methods of methicillin-resistance detection and evaluation of some properties of methicillin-resistant Staphylococcus aureus strains.
    Trzciński K; Zareba T; Tyski S; Hryniewicz W
    Acta Microbiol Pol; 1993; 42(1):23-8. PubMed ID: 7504871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of glycopeptide hetero-intermediate Staphylococcus aureus strains in Maltese hospitals.
    Borg MA; Zerafa R; Morrison D; Cuschieri P
    Clin Microbiol Infect; 2005 May; 11(5):405-7. PubMed ID: 15819869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Tarasi A; Cassone M; Monaco M; Tarasi D; Pompeo ME; Venditti M
    J Chemother; 2003 Jun; 15(3):239-43. PubMed ID: 12868549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Susceptibility to selected chemotherapeutics of Staphylococcus aureus strains resistant to methycyline isolated from clinical materials in the years 1991-1992 and 1997].
    Kochman M; Fordymacki P; Lawrynowicz-Paciorek M; Kałuzewski S; Mészáros J; Połowniak-Pracka H; Ochman E; Sztandar-Sztanderska M
    Med Dosw Mikrobiol; 1999; 51(3-4):187-98. PubMed ID: 10803247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
    Atahan E; Gul M; Ergun Y; Eroglu E
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhibitory and bactericidal activity and selection capacity of mutants resistant and tolerant to vancomycin in Staphylococcus aureus strains].
    Villar HE; Tuchscherr L; Arena M; Longo L; Laurino G; Hoffman M
    Enferm Infecc Microbiol Clin; 1999 Nov; 17(9):454-7. PubMed ID: 10614079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
    Drago L; De Vecchi E; Nicola L; Gismondo MR
    BMC Infect Dis; 2007 Sep; 7():111. PubMed ID: 17888153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection of resistance to glycopeptide antibiotics in staphylococci.
    Biavasco F; Giovanetti E; Varaldo PE
    J Chemother; 1991 Jan; 3 Suppl 1():166-8. PubMed ID: 12041756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital.
    Mallaval FO; Carricajo A; Delavenna F; Recule C; Fonsale N; Manquat G; Raffenot D; Rogeaux O; Aubert G; Tous J
    Clin Microbiol Infect; 2004 May; 10(5):459-61. PubMed ID: 15113326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of netilmicin against clinical isolates of methicillin resistant and susceptible Staphylococcus aureus.
    Manoharan A; Lalitha MK; Jesudason MV
    Natl Med J India; 1997; 10(2):61-2. PubMed ID: 9153980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Methicillin resistant Staphylococcus].
    Marin M
    Medicina (B Aires); 2002; 62 Suppl 2():30-5. PubMed ID: 12481486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.
    Cartolano GL; Cheron M; Benabid D; Leneveu M; Boisivon A;
    Clin Microbiol Infect; 2004 May; 10(5):448-51. PubMed ID: 15113324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sensitivity to vancomycin and teicoplanin of coagulase-negative staphylococci isolated from clinical specimens].
    Młynarczyk G; Młynarczyk A; Luczak M; Jeljaszewicz J
    Med Dosw Mikrobiol; 1999; 51(1-2):17-23. PubMed ID: 10865426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vitro selection of resistance of Staphylococcus aureus to teicoplanin and vancomycin.
    Watanakunakorn C
    J Antimicrob Chemother; 1990 Jan; 25(1):69-72. PubMed ID: 2138602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation into the efficacy of disinfectants against MRSA and vancomycin-resistant enterococci.
    Goroncy-Bermes P
    Zentralbl Hyg Umweltmed; 1998 Dec; 201(4-5):297-309. PubMed ID: 9916285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An outbreak of Staphylococcus aureus strains with reduced susceptibility to glycopeptides in a French general hospital.
    Pina P; Marliere C; Vandenesch F; Bedos JP; Etienne J; Allouch PY
    Clin Infect Dis; 2000 Nov; 31(5):1306-8. PubMed ID: 11073773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT; Liao CH; Teng LJ; Hsueh PR
    Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplanin.
    Cooper MA; Jin YF; Ashby JP; Andrews JM; Wise R
    J Antimicrob Chemother; 1990 Aug; 26(2):203-7. PubMed ID: 2145256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureus.
    Vaudaux P; Francois P; Berger-Bächi B; Lew DP
    J Antimicrob Chemother; 2001 Feb; 47(2):163-70. PubMed ID: 11157900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Pistella E; Falcone M; Baiocchi P; Pompeo ME; Pierciaccante A; Penni A; Venditti M
    Infez Med; 2005 Jun; 13(2):97-102. PubMed ID: 16220029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.